# Lymphoma, B-Cell, Marginal studies recruiting: 20 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials that are observational for Lymphoma, B-Cell, Marginal Zone that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Lymphoma, B-Cell, Marginal Zone studies: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/lymphoma-b-cell-marginal-zone

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 17, 2026 | NCT07711327 | Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy | Sponsor not shown (see the record) | Observational | Not yet recruiting | Atrial Fibrillation (AF), Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma, Marginal... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711327) |
| May 27, 2026 | NCT07609446 | Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma | The First Affiliated Hospital of Soochow University | Observational | Not yet recruiting | Indolent Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Mantle Cell Lymphoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07609446) |
| April 30, 2026 | NCT07558057 | Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study | Aarhus University Hospital | Observational | Not yet recruiting | Malignant Lymphoma - Lymphoplasmacytic, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma | 225 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07558057) |
| January 29, 2026 | NCT07376330 | Molecular and Cellular Characterization of MALT Lymphoma | International Extranodal Lymphoma Study Group (IELSG) | Observational | Not yet recruiting | MALT Lymphoma | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07376330) |
| November 18, 2025 | NCT07233720 | Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma | Henan Cancer Hospital | Observational | Recruiting | Marginal Zone Lymphoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07233720) |
| February 12, 2025 | NCT06823960 | Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient... | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Marginal Zone Lymphoma(MZL) | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06823960) |
| August 2, 2024 | NCT06534463 | Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE) | Ruijin Hospital | Observational | Recruiting | Marginal Zone Lymphoma | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06534463) |
| June 10, 2024 | NCT06449885 | A Cohort Study in Newly Diagnosed MZL | Fudan University | Observational | Recruiting | Marginal Zone Lymphoma | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06449885) |
| January 25, 2024 | NCT06224309 | Preliminary Assessment of \[18F\]BL40 in PET/CT Scans | British Columbia Cancer Agency | Observational | Recruiting | Diffuse Large B-cell Lymphoma, Multiple Myeloma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06224309) |
| November 30, 2023 | NCT06151730 | Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment... | Mayo Clinic | Observational | Recruiting | Chronic Lymphocytic Leukemia, Hematopoietic and Lymphoid System Neoplasm, Mantle Cell Lymphoma, Marginal Zone Lymphoma... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06151730) |
| September 21, 2023 | NCT06043011 | Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms | iOMEDICO AG | Observational | Recruiting | Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell... | 2,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06043011) |
| June 28, 2023 | NCT05923502 | (CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL) | Ruijin Hospital | Observational | Not yet recruiting | Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Richter Syndrome, Marginal Zone Lymphoma... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05923502) |
| February 21, 2023 | NCT05735704 | Early Detection and Screening of Hematological Malignancies - SANGUINE | JaxBio Ltd | Observational | Recruiting | Hematologic Malignancy | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05735704) |
| January 26, 2023 | NCT05700149 | Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma | International Extranodal Lymphoma Study Group (IELSG) | Observational | Recruiting | Nodal Marginal Zone Lymphoma | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05700149) |
| April 13, 2022 | NCT05326308 | Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma | iOMEDICO AG | Observational | Recruiting | Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma, Follicular Lymphoma | 845 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05326308) |
| March 11, 2019 | NCT03869619 | REal World Data in LYmphoma and Survival in Adults | Hospices Civils de Lyon | Observational | Recruiting | Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL)... | 6,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03869619) |
| March 2, 2018 | NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | Massive Bio, Inc. | Observational | Recruiting | Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver, Cancer of Stomach, Cancer Liver, Cancer of Rectum... | 50,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03452774) |
| June 4, 2010 | NCT01137825 | Registry of Older Patients With Cancer | UNC Lineberger Comprehensive Cancer Center | Observational | Recruiting | Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, Leukemia, Lymphoma, Lymphoproliferative Disorder... | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01137825) |
| June 4, 2010 | NCT01137643 | Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer | UNC Lineberger Comprehensive Cancer Center | Observational | Recruiting | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma... | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01137643) |
| June 18, 2009 | NCT00923507 | Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)... | National Heart, Lung, and Blood Institute (NHLBI) | Observational | Recruiting | Waldenstrom Macroglobulinemia, Lymphoplasmacytic Lymphoma, Monoclonal B-Cell Lymphocytosis, Small Lymphocytic Lymphoma... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00923507) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 2 |
| International Extranodal Lymphoma Study Group (IELSG) | 2 |
| Ruijin Hospital | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Mayo Clinic | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Henan Cancer Hospital | 1 |
| Massive Bio, Inc. | 1 |
| JaxBio Ltd | 1 |
| British Columbia Cancer Agency | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Aarhus University Hospital | 1 |
| Hospices Civils de Lyon | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
| Fudan University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 7 |
| China | 4 |
| Italy | 3 |
| Germany | 2 |
| Canada | 2 |
| France | 2 |
| Argentina | 1 |
| Armenia | 1 |
| Croatia | 1 |
| India | 1 |
| Netherlands | 1 |
| Poland | 1 |
| Portugal | 1 |
| South Korea | 1 |
| Spain | 1 |
| Switzerland | 1 |
| United Kingdom | 1 |
| Austria | 1 |
| Puerto Rico | 1 |
| Czechia | 1 |
| Greece | 1 |
| Israel | 1 |
| Lithuania | 1 |
| Denmark | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Real estate investment firms in the United States](https://specstream.ai/data/businesses/real-estate-investment-firms/united-states)
- [Ecuadorian restaurants in the United States](https://specstream.ai/data/businesses/ecuadorian-restaurants/united-states)
- [Social media agencies in the United States](https://specstream.ai/data/businesses/social-media-agencies/united-states)
- [Fastener suppliers in the United States](https://specstream.ai/data/businesses/fastener-suppliers/united-states)
- [Textile manufacturers in the United States](https://specstream.ai/data/businesses/textile-manufacturers/united-states)
- [Gluten free restaurants in the United States](https://specstream.ai/data/businesses/gluten-free-restaurants/united-states)
